- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/17 - Amides, e.g. hydroxamic acids having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine
Patent holdings for IPC class A61K 31/17
Total number of patents in this class: 1410
10-year publication summary
|
96
|
93
|
88
|
96
|
108
|
73
|
79
|
77
|
86
|
19
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2259 |
33 |
| The Regents of the University of California | 20447 |
31 |
| Lantern Pharma Inc. | 82 |
26 |
| Bristol-myers Squibb Company | 4793 |
21 |
| Hope Medical Enterprises, Inc. | 56 |
12 |
| The Regents of the University of Michigan | 4869 |
10 |
| Duke University | 3167 |
10 |
| Remedy Pharmaceuticals, Inc. | 59 |
10 |
| Royalty Security, LLC | 20 |
10 |
| The Board of Trustees of the Leland Stanford Junior University | 6597 |
9 |
| Arete Therapeutics, Inc. | 23 |
9 |
| Neoculi Pty Ltd | 18 |
9 |
| The Board of Trustees of the University of Illinois | 2744 |
8 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3102 |
8 |
| Société des Produits Nestlé S.A. | 9938 |
7 |
| Cornell University | 3385 |
7 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1005 |
7 |
| Azura Ophthalmics Ltd. | 81 |
7 |
| Jnana Therapeutics, Inc. | 35 |
7 |
| Lpoxy Therapeutics, Inc | 27 |
7 |
| Other owners | 1162 |